Drug intelligence / Profile preview

alcohol + perampanel

Development stage
Unknown
Lead developer
Eisai
Modality
Small Molecules
Administration
Oral
01

Overview

This entry refers to the combination of alcohol (ethanol) and perampanel. Alcohol is a central nervous system depressant commonly consumed as a recreational beverage. Perampanel is an oral antiepileptic drug used primarily for the treatment of partial-onset seizures and primary generalized tonic-clonic seizures. Perampanel acts as a selective, non-competitive antagonist of the AMPA receptor, thereby reducing abnormal neuronal excitation in the brain[3][4][6]. The combination of these two substances is clinically significant because co-administration can increase central nervous system depression and significantly worsen psychiatric side effects such as mood changes and increased anger[1][2][5][8]. Patients taking perampanel are advised to avoid or limit alcohol consumption due to additive or supra-additive impairment in cognition, vigilance, alertness, and increased risk for behavioral adverse reactions.

Brand names
Fycompa
Other names
ethanol2-propanol
02

Targets

AMPAR (AMPA receptor)

Beyond the preview

Go deeper on alcohol + perampanel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alcohol + perampanel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call